Open AccessIn Silico Drug Repurposing of 9H-Thioxanthene Based FDA-Approved Drugs as Potent Chemotherapeutics Targeting VEGFR-2 and COX-2
Author(s) -
Shazia Parveen,
Rua B. Alnoman,
Abeer Aljohani,
Alhanouf Aljohani,
Ibtisam Alotaibi,
Leena Al-Juhani,
M.A. Al-Johani,
Rawan Aljohani
Publication year - 2022
Publication title -
biointerface research in applied chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.216
H-Index - 11
ISSN - 2069-5837
DOI - 10.33263/briac134.372
Subject(s) - drug repositioning , pharmacology , drug , adme , in silico , lipinski's rule of five , repurposing , approved drug , pharmacokinetics , chemistry , medicine , biology , ecology , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom